Literature DB >> 14506659

Engraftment of quiescent progenitors and conversion to full chimerism after nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine.

Brian Lima1, Zachary L Gleit, Andrew M Cameron, Sharon Germana, Michael C Murphy, Robert Consorti, Qing Chang, Julian D Down, Christian LeGuern, David H Sachs, Christene A Huang.   

Abstract

Our laboratory has previously reported a nonmyelosuppressive preparative regimen for hematopoietic cell transplantation that leads to mixed chimerism and allograft tolerance in miniature swine across minor and major histocompatibility disparities. Stable chimerism persisted in most of these animals but was restricted to T cells and confined to peripheral blood. Because of the importance of myeloid and erythroid progenitors for the treatment of hematologic disorders, the objective of this study was to assess whether such cells existed in the bone marrow of these lymphoid chimeras as an indication of functional engraftment. Colony-formation assays were performed on donor inocula before infusion and on bone marrow cells harvested from the transplant recipients. Donor-origin myeloid/erythroid progenitor colonies were detected in bone marrow from 6 of 7 lymphoid chimeric recipients. A delayed donor leukocyte infusion successfully converted a stable lymphoid chimera to full multilineage chimerism within 2 weeks. Donor-origin myeloid/erythroid progenitors could be detected in the bone marrow of a host-matched recipient after myeloablation and adoptive transfer of mobilized cells from one of the engrafted lymphoid chimeras. These data suggest that even when only lymphoid chimerism is readily detected by flow cytometry, dormant myeloid/erythroid progenitors can exist and subsequent conversion to full donor chimerism can be achieved. The ability to establish multilineage engraftment and chimerism without significant toxicity may have important clinical implications for the management of nonmalignant hematopoietic disorders and hematologic malignancies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506659     DOI: 10.1016/s1083-8791(03)00227-1

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  4 in total

Review 1.  Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.

Authors:  David H Sachs; Megan Sykes; Tatsuo Kawai; A Benedict Cosimi
Journal:  Semin Immunol       Date:  2011-08-11       Impact factor: 11.130

2.  Vascularized composite allograft tolerance across MHC barriers in a large animal model.

Authors:  D A Leonard; J M Kurtz; C Mallard; A Albritton; R Duran-Struuck; E A Farkash; R Crepeau; A Matar; B M Horner; M A Randolph; D H Sachs; C A Huang; C L Cetrulo
Journal:  Am J Transplant       Date:  2014-01-09       Impact factor: 8.086

3.  Expression and purification of non-N-glycosylated porcine interleukin 3 in yeast Pichia pastoris.

Authors:  Christina E Hermanrud; Vimukthi Pathiraja; Abraham Matar; Raimon Duran-Struuck; Rebecca L Crepeau; Srimathi Srinivasan; David H Sachs; Christene A Huang; Zhirui Wang
Journal:  Protein Expr Purif       Date:  2011-12-01       Impact factor: 1.650

4.  Effects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine.

Authors:  Abraham J Matar; Rebecca L Crepeau; Vimukthi Pathiraja; Simon Robson; Jay A Fishman; Thomas R Spitzer; David H Sachs; Christene A Huang; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.